For patients with significant sleep quality issues, both may be used synergistically
HUBERMAN: And that's one of the major issues with BPC-157 that's not often discussed, which is that if you have a tumor, and tumors thrive on increased blood flow because they like to consume growth factors and increased blood flow means increased growth factors and other things that can not just sustain but actually grow the tumor, well then by taking BPC-157, you may be either maintaining or accelerating the growth of a tumor that would otherwise be removed or stay small
Tirzepatide is a dual glp-1/gip receptor agonist FDA-approved for weight loss and type 2 diabetes
Pylori, SIBO, or SIFO, but nothing else is helping you support gut imbalances, you might consider BPC-157
Cholelithiasis (gallstones) like GLP-1, due to rapid weight loss
Red flags requiring urgent assessment include rapidly progressive neurological symptoms, new onset ataxia or gait disturbance, visual changes, severe weakness, or confusion